In order to exclude that vimentin+ cells in tumor areas represented infiltrating non-tumor cells, selected tumor specimens were stained with vimentin- and either CD31- (endothelial cells), CD68- (monocytes/macrophages), or CD90-specific antibodies (fibroblasts), respectively. This evidence concerns the gene VIM and neoplasm.